These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. The role of the serine protease active site in the mode of action of epidermolytic toxin of Staphylococcus aureus. Redpath MB; Foster TJ; Bailey CJ FEMS Microbiol Lett; 1991 Jun; 65(2):151-5. PubMed ID: 1884990 [TBL] [Abstract][Full Text] [Related]
29. Detection and genetic characterization of PVL-positive ST8-MRSA-IVa and exfoliative toxin D-positive European CA-MRSA-Like ST1931 (CC80) MRSA-IVa strains in Bangladesh. Paul SK; Ghosh S; Kawaguchiya M; Urushibara N; Hossain MA; Ahmed S; Mahmud C; Jilani MS; Haq JA; Ahmed AA; Kobayashi N Microb Drug Resist; 2014 Aug; 20(4):325-36. PubMed ID: 24552553 [TBL] [Abstract][Full Text] [Related]
30. Association of toxic shock syndrome toxin-secreting and exfoliative toxin-secreting Staphylococcus aureus with Kawasaki syndrome complicated by coronary artery disease. Leung DY; Sullivan KE; Brown-Whitehorn TF; Fehringer AP; Allen S; Finkel TH; Washington RL; Makida R; Schlievert PM Pediatr Res; 1997 Sep; 42(3):268-72. PubMed ID: 9284264 [TBL] [Abstract][Full Text] [Related]
31. Prevalence of Staphylococcus aureus toxins and nasal carriage in furuncles and impetigo. Durupt F; Mayor L; Bes M; Reverdy ME; Vandenesch F; Thomas L; Etienne J Br J Dermatol; 2007 Dec; 157(6):1161-7. PubMed ID: 17916211 [TBL] [Abstract][Full Text] [Related]
32. [Experimental studies on the mechanism of the action of staphylococcal epidermolytic toxin A utilizing recombinant toxin]. Inaoki M Nihon Hifuka Gakkai Zasshi; 1990 Dec; 100(14):1405-14. PubMed ID: 2082042 [TBL] [Abstract][Full Text] [Related]
33. Preliminary crystallographic data for exfoliative toxin B from Staphylococcus aureus. Moras D; Thierry JC; Cavarelli J; Piémont Y J Mol Biol; 1984 May; 175(1):89-91. PubMed ID: 6726805 [TBL] [Abstract][Full Text] [Related]
34. Staphylococcal exfoliative toxins: "molecular scissors" of bacteria that attack the cutaneous defense barrier in mammals. Nishifuji K; Sugai M; Amagai M J Dermatol Sci; 2008 Jan; 49(1):21-31. PubMed ID: 17582744 [TBL] [Abstract][Full Text] [Related]
35. Role of Staphylococcus aureus exfoliatin toxin in staphylococcal infections in mice. Shibl AM Chemotherapy; 1981; 27(3):224-7. PubMed ID: 7226975 [TBL] [Abstract][Full Text] [Related]
36. Acid and neutral sphingomyelinase, ceramide synthase, and acid ceramidase activities in cutaneous aging. Jensen JM; Förl M; Winoto-Morbach S; Seite S; Schunck M; Proksch E; Schütze S Exp Dermatol; 2005 Aug; 14(8):609-18. PubMed ID: 16026583 [TBL] [Abstract][Full Text] [Related]
37. Preliminary crystallographic data for Staphylococcus aureus exfoliative toxin. Yoo CS; Wang BC; Sax M; Johnson AD J Mol Biol; 1978 Sep; 124(2):421-3. PubMed ID: 712842 [No Abstract] [Full Text] [Related]
38. [A simple method of purifying staphylococcal alpha-toxin and a study of its properties]. Beĭlbaeva ML; Bukharova TB; Ezepchuk IuV Mol Gen Mikrobiol Virusol; 1991 Sep; (9):28-30. PubMed ID: 1745273 [TBL] [Abstract][Full Text] [Related]
39. Understanding the mechanism of action of the exfoliative toxins of Staphylococcus aureus. Ladhani S FEMS Immunol Med Microbiol; 2003 Nov; 39(2):181-9. PubMed ID: 14625102 [TBL] [Abstract][Full Text] [Related]
40. Identification of a novel Staphylococcus pseudintermedius exfoliative toxin gene and its prevalence in isolates from canines with pyoderma and healthy dogs. Iyori K; Hisatsune J; Kawakami T; Shibata S; Murayama N; Ide K; Nagata M; Fukata T; Iwasaki T; Oshima K; Hattori M; Sugai M; Nishifuji K FEMS Microbiol Lett; 2010 Nov; 312(2):169-75. PubMed ID: 20875053 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]